Romiplostim for the treatment of chronic immune thrombocytopenia

Technology appraisal guidance
Reference number: TA221
Published: 27 April 2011
Last updated: 26 October 2018

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from GlasxoSmithKline

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from GlasxoSmithKline

Thrombocytopenic purpura - romiplostim: consultee and commentator comments on the ACD received from GlasxoSmithKline
17 March 2011
(208.71 Kb 1 mins )

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 March 2011